Additive inhibitory effects of retinoids and interferon-α on the growth of human cervical carcinoma cells: Lack of association with HPV status or retinoid receptor expression

International Journal of Oncology

Volumn 8, Issue 1, 1996, Pages 5-13

  Lotan, Reuben ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

cervical cancer; interferon alpha; retinoid receptors; retinoids

Indexed keywords

ALPHA2A INTERFERON; RETINOIC ACID; RETINOID; RETINOID RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DRUG POTENTIATION; GROWTH INHIBITION; HUMAN; HUMAN CELL; PAPILLOMA VIRUS; PRIORITY JOURNAL; TUMOR CELL LINE; UTERINE CERVIX CARCINOMA;

EID: 0030038856     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Munoz N and Bosch F: Epidemiology of cervical cancer. In: Human Papillomavirus. Munoz N, Bosch F and Jensen O (eds). Oxford Press, New York pp9-39, 1989.
2. Mitchell MF, Hittelman. W, Hong WK, Lotan R and Schottenfeld D: The natural history of cervical intraepithelial neoplasia: An argument for intermediate endpoint biomarkers. Cancer Epidem Biomarker Prev 3: 619-626, 1994.
3. Wingo PA, Tong T and Bolden S: Cancer statistics, 1995. CA Cancer J Clin 45: 8-30, 1995.
4. Hoskins WJ, Ferez C and Young RC: Gynecologic tumors. In: Cancer: Principles and Practice of Oncology. DeVita VT, Hellman S and Rosenberg SA (eds). Lippincott, Philadelphia pp1099-1161, 1989.
5. Perez CA, Kurman RJ and Stehman FB: Uterine cervix. In: Principles and Practice of Gynecologic Oncology. Hoskins WJ, Perez C and Young RC (eds). Lippincott, Philadelphia pp591-662, 1992.
6. Lotan R, Francis GE, Freeman CS and Waxman S: Differentiation therapy. Cancer Res 50: 3453-3464, 1990.
7. Bollag W and Holdener EE: Retinoids in cancer prevention and therapy. Ann Oncol 3: 513-526, 1992.
8. Hong WK and Itri LM: Retinoids and human cancer. In: The Retinoids. Sporn MB, Roberts AB and Goodman DS (eds). Raven Press, New York pp597-658, 1994.
9. Borden EC, Lotan R, Levens D, Young CW and Waxman S: Differentiation therapy of cancer: laboratory and clinical investigations. Cancer Res 53: 4109-4115, 1993.
10. Borden EC: Interferons - expanding therapeutic roles. N Engl J Med 326: 1491-1493, 1992.
11. Lippman SM, Kavanagh JJ, Paredes-Espinoza M, DelgadilloMadrueno F, Paredes-Castillas P, Hong WK, Holdener E and Krakoff IH: 13-cis-retinoic acid plus interferon-α2a: Highly active systemic therapy for squamous cell carcinoma of the cervix. J Natl Cancer Inst 84: 241-245. 1992.